Last reviewed · How we verify
Thiosinaminum (ALLYLTHIOUREA)
Thiosinaminum (generic name: ALLYLTHIOUREA) is a Small molecule drug developed by Washington Homeopathic Products. It is currently FDA-approved for Scarring.
Thiosinaminum is a small molecule with the synonyms ALILTIOUREA, ALLYLTHIOUREA, ALLYLTHIOUREE, NSC-1915, THIOSINAMINE, and THIOSINAMINUM.
At a glance
| Generic name | ALLYLTHIOUREA |
|---|---|
| Sponsor | Washington Homeopathic Products |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | FDA-approved |
Approved indications
- Scarring
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Thiosinaminum CI brief — competitive landscape report
- Thiosinaminum updates RSS · CI watch RSS
- Washington Homeopathic Products portfolio CI
Frequently asked questions about Thiosinaminum
What is Thiosinaminum?
Thiosinaminum (ALLYLTHIOUREA) is a Small molecule drug developed by Washington Homeopathic Products, indicated for Scarring.
What is Thiosinaminum used for?
Thiosinaminum is indicated for Scarring.
Who makes Thiosinaminum?
Thiosinaminum is developed and marketed by Washington Homeopathic Products (see full Washington Homeopathic Products pipeline at /company/washington-homeopathic-products).
What is the generic name of Thiosinaminum?
ALLYLTHIOUREA is the generic (nonproprietary) name of Thiosinaminum.
What development phase is Thiosinaminum in?
Thiosinaminum is FDA-approved (marketed).
Related
- Manufacturer: Washington Homeopathic Products — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Scarring
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing